Granulocyte colony-stimulating factor enhances the angiogenetic effect of indirect bypass surgery for chronic cerebral hypoperfusion in a rat model

Neurosurgery

Volumn 68, Issue 5, 2011, Pages 1372-1379

  Ohmori, Yuki ^a   Morioka, Motohiro ^a   Kaku, Yasuyuki ^a   Kawano, Takayuki ^a   Kuratsu, Jun Ichi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Cerebral blood flow; Granulocyte colony stimulating factor; Hypoperfusion Indirect bypass

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILATERAL INTERNAL CAROTID ARTERY OCCLUSION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; BRAIN DISEASE; BYPASS SURGERY; CHRONIC CEREBRAL HYPOPERFUSION; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALOGALEOSYNANGIOSIS; IMMUNOHISTOCHEMISTRY; INDIRECT BYPASS SURGERY; INTERNAL CAROTID ARTERY OCCLUSION; LASER DOPPLER FLOWMETRY; MALE; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

ANGIOGENIC PROTEINS; ANIMALS; CEREBRAL INFARCTION; CEREBRAL REVASCULARIZATION; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 79955006422     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31820c0289     Document Type: Article

References (45)

1. Coyle P, Panzenbeck MJ. Collateral development after carotid artery occlusion in Fischer 344 rats. Stroke. 1990;21(2):316-321. (Pubitemid 20067938)
2. Jet Study Group. Japanese EC-IC Bypass Trial (JET Study): the second interim analysis. Surg Cereb Stroke (Jpn). 2002;30:434-437.
3. The EC-IC bypass study. N Engl J Med. 1987;317(16):1030-1032.
4. Karasawa J, Kikuchi H, Furuse S, et al. A surgical treatment of "moyamoya" disease: "encephalo-myo-synangiosis." Neurol Med Chir (Tokyo). 1977;17(1 Pt 1): 29-37.
5. Matsushima Y, Fukai N, Tanaka K, et al. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol. 1981;15(4):313-320. (Pubitemid 11096180)
6. Ozgur BM, Aryan HE, Levy ML. Indirect revascularization for paediatric moyamoyadisease: theEDAMS technique. JClinic Neurosc. 2006;13(1):105-108. (Pubitemid 43061138)
7. Shirane R, Yoshida Y, Takahashi T, Yoshimoto T. Assessment of encephalo-galeo-myo-synangiosis with dural pedicle insertion in childhood Moyamoya disease: characteristics of cerebral blood flow and oxygen metabolism. Clin Neurol Neu-rosurg. 1997;99(suppl 2):79-85.
8. Nakamura M, Imai H, Konno K, et al. Experimental investigation of encepha-lomyosynangiosis using gyrencephalic brain ofthe miniature pig: histopathological evaluation of dynamic reconstruction of vessels for functional anastomosis. J Neurosurg Pediatr. 2009;3(6):488-495.
9. Nagata S, Tsuchiya M, Asano S, et al. Molecular cloning and expression ofcDNA for human granulocyte colony-stimulating factor. Nature. 1986;319(6052):415-418. (Pubitemid 16163903)
10. Morstyn G, Lieschke GJ, Sheridan W, Layton J, Cebon J, Fox RM. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. Semin Hematol. 1989;26(2 suppl 2):9-13. (Pubitemid 19246045)
11. Neidhart J, Mangalik A, Kohler W, et al. Granulocyte colony-stimulating factor stimulates recovery ofgranulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. J Clin Oncol. 1989;7(11):1685-1692. (Pubitemid 19272840)
12. Sheridan WP, Morstyn G, Wolf M, et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet. 1989;2(8668):891-895.
13. Gibson CL, Bath PM, Murphy SP. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2005;25(4):431-439.
14. Matchett GA, Calinisan JB, Matchett GC, Martin RD, Zhang JH. The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats. Brain Res. 2007;1136(1):200-207. (Pubitemid 46209079)
15. Schabitz W, Kollmar M, Schwaninger E, Juettler J, Bardutzky M, Scholzke N. Neuroprotective effect ofgranulocyte colony stimulating factor after focal cerebral ischemia. Stroke. 2003;34(3):745-751. (Pubitemid 36307405)
16. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. Can Med Assoc J. 2006;174(7):927-933.
17. Six I, Gasan G, Mura E, Bordet R Beneficial effect ofpharmacological mobili-zation of bone marrow in experimental cerebral ischemia. Eur Pharmacol. 2003;458(3):327-328. (Pubitemid 36009473)
18. Solaroglu IS, Cahill J, Jadhav V, Zhang JH. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke. 2006;37(4):1123-1128.
19. Lee ST, Chu K, Jung KH, et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 2005;1058(1-2):120-128. (Pubitemid 41416806)
20. Piao CS, Gonzalez-Toledo ME, Xue YQ, et al. The role of stem cell factor and granulocyte-colony stimulating factor in brain repair during chronic stroke. J Cereb Blood Flow Metab. 2009;29(4):759-770.
21. Sehara Y, Hayashi T, Deguchi K, et al. Potentiation ofneurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res. 2007;1151:142-149. (Pubitemid 46709859)
22. Toth ZE, Leker RR, Shahar T, et al. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Blood. 2008;111(12):5422-5423.
23. Hasegawa Y, Hamada J, Morioka M, et al. Neuroprotective effect ofpostischemic administration of sodium orthovanadate in rats with transient middle cerebral artery occlusion. J Cereb Blood Flow Metab. 2003;23(9):1040- 1051. (Pubitemid 37082429)
24. Ulrich PT, Kroppenstedt S, Heimann A, et al. Laser-doppler scanning of local cerebral blood flow and reserve capacity and testing of motor and memory functions in a chronic 2-vessel occlusion model in rats. Stroke. 1998;29(11):2412-2420. (Pubitemid 28511966)
25. Folkman J, Merler E, Abernathy C, et al. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971;133(2):275-288.
26. Gupta R, Tongers J, Losordo DW. Human studies of angiogenetic gene therapy. Circ Res. 2009;105(8):724-736.
27. Kusaka N, Sugiu K, Tokunaga K, et al. Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration ofplasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neuro-surg. 2005;103(5):882-890. (Pubitemid 43194583)
28. Sevimli S, Diederich K, Strecker JK, et al. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol. 2009;217(2):328-335.
29. Grigg AP, Roberts AW, Raunow H, et al. Optimizing dose and scheduling offilgrastism (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood. 1995;86(12):4437-4445.
30. Taguchi A, Soma T, Tanaka H, et al. Administration of CD34(+) cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004;114(3):330-338. (Pubitemid 39071605)
31. Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res. 2002;90(3):284-288. (Pubitemid 34633929)
32. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T. Isolation ofputative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964-967. (Pubitemid 27087709)
33. Natori T, Sata M, Washida M, Hirata Y, Nagai R, Makuuchi M. GCSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun. 2002;297:1058-1061. (Pubitemid 35230360)
34. Bussolino F, Ziche M, Wang JM, et al. In vitro and in vivo activation of en-dothelial cells by colony-stimulating factors.J Clin Invest. 1991;87(3):986-995.
35. Ohki Y, Heissig B, Sato Y, et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neu-trophils. FASEB J. 2005;19(14):2005-2007. (Pubitemid 41759746)
36. Houkin K, Ishikawa T, Yoshimoto T, Abe H. Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg. 1997;99(Suppl 2):S142-S145. (Pubitemid 27489083)
37. Ishikawa T, Houkin K, Kamiyama H, Abe H. Effects ofsurgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke. 1997;28(6):1170-1173. (Pubitemid 27248890)
38. Lee SK, Kim DI, Jeong EK, et al. Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol. 2003;24(4):741-747. (Pubitemid 36460752)
39. Matsushima Y, Aoyagi M, Koumo Y, Takasato Y, Yamaguchi T, Masaoka H. Effects of encephalo-duro-arterio-synangiosis on childhood moyamoya patients\swift disappearance of ischemic attacks and maintenance of mental capacity. Neurol Med Chir (Tokyo). 1991;31(11):708-714.
40. Han DH, Nam DH, Oh CW. Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis. Clin Neurol Neurosurg. 1997;99(suppl 2):S151-S155.
41. Starke RM, Komotar RJ, Hickman ZL, et al. Clinical features, surgical treatment and long-term outcome in adult patients with moyamoya disease. J Neurosurg. 2009;111(5):936-942.
42. Komotar RJ, Starke RM, Otten ML, et al. The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. JNeurosurg. 2009;110(5):896-904.
43. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593-600. (Pubitemid 36204953)
44. Rafat N, Beck GH, Pena-Tapia PG, Schmiedek P, Vajkoczy P. Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease. Stroke. 2009;40(2):432-438.
45. Bruno S, Bussolati B, Scacciatella P, et al. Combined administration ofG-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine. 2006;34(1-2):56-65. (Pubitemid 43817553)